Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",49205,298,1.86 [1.38-2.49],3.524628556087992e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",50993,391,1.72 [1.32-2.24],5.483949107245525e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",50466,2761,1.49 [1.35-1.66],1.4621348107045565e-14
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Candidiasis,51030,845,1.64 [1.37-1.97],1.1165368501370925e-07
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,49487,6974,1.37 [1.28-1.46],5.4726100858576895e-21
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),49675,6375,1.56 [1.46-1.67],9.730658514255451e-38
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,50529,2432,1.48 [1.33-1.65],2.2988340262536133e-12
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,50848,172,2.11 [1.45-3.06],8.46246886174857e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,46938,1939,1.88 [1.66-2.12],2.5204944298749395e-24
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,45348,2199,2.01 [1.80-2.25],2.590184053433913e-34
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,45094,511,2.29 [1.83-2.85],2.767160192965408e-13
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,35855,3952,1.63 [1.50-1.77],3.876611408014733e-29
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,44792,779,2.16 [1.80-2.60],1.5388956156469343e-16
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,50957,2860,1.46 [1.32-1.61],2.274892090366696e-13
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Mycoses,51183,998,1.57 [1.32-1.86],1.865758988870421e-07
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,49557,1852,1.65 [1.46-1.87],9.844267733524929e-16
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,51046,2139,1.72 [1.53-1.92],7.369694458138016e-21
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,48490,393,1.73 [1.33-2.25],4.069882760290143e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,51284,100,1.62 [0.95-2.75],0.0747507644597316
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Other septicaemia,50778,1871,1.79 [1.59-2.02],1.2185873519244469e-21
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,50825,149,1.29 [0.83-2.02],0.2605912785985748
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Other viral diseases,51124,309,1.75 [1.30-2.36],0.0002135644169142
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",51085,270,1.50 [1.08-2.08],0.0156714654953836
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,48543,838,1.97 [1.66-2.34],1.518633255550087e-14
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,48261,556,1.22 [0.96-1.54],0.0968547927651278
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,48314,217,1.94 [1.38-2.73],0.0001293630754351
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,51240,103,2.01 [1.22-3.32],0.0064979151873882
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,51155,300,1.16 [0.84-1.59],0.3741955052759537
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Viral warts,50956,101,1.09 [0.63-1.90],0.7493453262899434
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],50979,124,1.25 [0.76-2.04],0.3810283147881182
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,Benign lipomatous neoplasm,50696,587,1.00 [0.79-1.26],0.9921407540797832
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,51106,116,0.82 [0.48-1.38],0.450791596197588
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,51070,126,0.71 [0.43-1.17],0.1801098612725213
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,23567,131,1.10 [0.68-1.80],0.69115938469691
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",50622,2869,1.10 [0.99-1.22],0.0641898453018222
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,Benign neoplasm of meninges,51256,115,1.02 [0.60-1.71],0.95469845708657
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,51156,129,1.34 [0.83-2.17],0.2371463811873498
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,51234,210,1.18 [0.81-1.73],0.3807220917529503
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,Benign neoplasm of ovary,27582,177,0.80 [0.52-1.22],0.2986281364365026
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,Benign neoplasm: Ascending colon,51238,715,1.05 [0.85-1.29],0.6681687914961751
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,Benign neoplasm: Caecum,51238,590,1.13 [0.90-1.42],0.2820808202634418
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",51067,146,1.14 [0.72-1.80],0.5727154352991063
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,Benign neoplasm: Descending colon,51232,429,1.01 [0.77-1.32],0.9593560411507124
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,Benign neoplasm: Rectum,51153,710,1.23 [1.00-1.51],0.0504300494544171
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,51058,1240,1.09 [0.93-1.28],0.2729591611382383
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,Benign neoplasm: Transverse colon,51218,857,1.12 [0.93-1.36],0.2235017785754264
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,Carcinoma in situ of breast,22413,140,1.15 [0.71-1.85],0.5668521533283521
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",22505,169,1.02 [0.66-1.58],0.9328888919172776
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",40826,102,1.70 [1.00-2.89],0.048278888840104
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",40863,139,1.82 [1.16-2.87],0.0095512227668945
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",51183,239,1.44 [1.01-2.05],0.0425248950747049
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,"Haemangioma, any site",51184,234,1.45 [1.01-2.06],0.0421909476704852
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,Leiomyoma of uterus,26676,589,1.07 [0.85-1.34],0.5600628035794346
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,Lung cancer and mesothelioma,35558,656,1.18 [0.94-1.47],0.1585521927006251
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,Lymphoid leukaemia,40827,103,1.70 [1.00-2.90],0.0500321234860384
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",41093,369,1.63 [1.23-2.17],0.0007472856762113
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",41125,401,1.27 [0.96-1.67],0.093422429711319
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",22638,187,0.83 [0.54-1.25],0.3704942975532763
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",40885,161,1.30 [0.84-2.00],0.2394026045101932
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",40935,211,1.62 [1.12-2.34],0.01091925694324
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",40919,195,1.02 [0.68-1.52],0.9392447047163616
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",22592,141,0.86 [0.53-1.39],0.5404797171196589
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",40908,184,1.10 [0.73-1.66],0.654823603158698
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",19676,1403,0.99 [0.85-1.15],0.8485297771262212
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",40953,229,0.80 [0.55-1.17],0.2536029628318101
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",40873,149,1.23 [0.78-1.95],0.3636702055953288
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,40934,210,0.99 [0.67-1.47],0.9564188647841552
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,Melanocytic naevi,50896,402,1.03 [0.78-1.36],0.8564276434601221
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,Melanocytic naevi of trunk,51207,175,1.04 [0.68-1.60],0.8447186510961447
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,Melanoma in situ,40789,160,1.06 [0.68-1.67],0.7908520988727762
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",40905,181,1.96 [1.32-2.89],0.0007363561538582
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",41045,321,1.87 [1.39-2.52],3.3620456648364745e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",41171,447,0.96 [0.73-1.26],0.7716104221218884
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",40920,196,1.92 [1.32-2.80],0.0006973357978638
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,Other benign neoplasms of skin,50926,305,1.16 [0.84-1.60],0.3592362280730117
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",42863,2139,1.04 [0.92-1.18],0.5386410874598977
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",42975,2251,1.05 [0.93-1.19],0.3972557022245743
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,50702,686,1.69 [1.38-2.07],2.9492849467267084e-07
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,47515,226,3.55 [2.82-4.46],1.8780335737449536e-27
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,50156,140,1.47 [0.94-2.32],0.093819561296527
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,49698,5764,1.58 [1.47-1.69],1.4498423307994698e-36
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,48361,99,1.77 [1.05-2.98],0.0322303823144712
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,50448,96,2.76 [1.78-4.29],6.43850138639466e-06
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,50307,3018,1.62 [1.47-1.79],1.1421457063674151e-22
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,50305,3016,1.62 [1.47-1.79],1.220641560762645e-22
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,47463,174,2.52 [1.79-3.56],1.3660950677453316e-07
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,50629,2367,1.75 [1.58-1.95],9.54965037914027e-25
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,50579,227,1.80 [1.28-2.53],0.0008023635402621
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,50142,126,1.63 [1.02-2.61],0.0407921614204786
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,50134,118,1.05 [0.63-1.75],0.8644028695328615
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,50901,549,2.30 [1.88-2.82],6.418900830429749e-16
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,51077,110,2.95 [1.99-4.39],9.022727871347645e-08
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",50808,456,2.54 [2.05-3.14],7.288951319557251e-18
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,48474,212,1.48 [1.02-2.14],0.0372997222549349
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,39664,632,2.41 [1.98-2.94],4.515544865039836e-18
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,47831,231,0.69 [0.48-1.00],0.0500247453153459
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,47853,253,0.81 [0.57-1.16],0.2447965596079502
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,39140,108,1.24 [0.72-2.13],0.444897545859745
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,47630,137,1.82 [1.17-2.83],0.0078688034891439
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,46518,473,1.47 [1.14-1.89],0.002645299190383
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",50343,1138,1.54 [1.32-1.81],8.468423626684423e-08
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,49736,531,1.33 [1.04-1.69],0.02089163102087
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,49457,252,1.16 [0.82-1.64],0.4116704971774803
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,50577,3084,1.37 [1.24-1.51],2.3147015071271551e-10
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,44682,2989,1.34 [1.22-1.49],8.065448390130879e-09
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",39165,133,1.82 [1.14-2.89],0.0116167518181636
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",47283,159,1.47 [0.96-2.25],0.079439216765765
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,39595,563,1.56 [1.24-1.97],0.0001443729834698
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,39152,120,1.91 [1.18-3.11],0.0088557901413299
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,46058,7026,1.07 [1.00-1.14],0.0546799069762092
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,39420,388,1.53 [1.16-2.03],0.0026331582198528
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,40143,1111,1.44 [1.22-1.70],1.7957115653019528e-05
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,51124,646,1.30 [1.05-1.62],0.0155884476740099
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,50750,272,1.85 [1.36-2.51],9.458461198524524e-05
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,39285,253,1.11 [0.78-1.58],0.5729745023975261
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",39153,121,2.86 [1.90-4.31],4.749940448048734e-07
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,50211,3087,1.45 [1.31-1.60],7.58022253419942e-14
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,39551,519,2.98 [2.44-3.63],6.471270498826076e-27
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,39631,599,3.06 [2.54-3.68],5.985186961794307e-32
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",40286,1254,1.25 [1.06-1.46],0.0066107756783511
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,39271,239,2.40 [1.74-3.31],1.0662990685295093e-07
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,50733,255,1.80 [1.30-2.47],0.0003572770595034
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,40238,1206,1.64 [1.40-1.92],5.36443981930131e-10
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,39992,960,1.44 [1.21-1.72],6.167591043318752e-05
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,46184,139,1.73 [1.11-2.72],0.0166058407389773
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,48937,9905,1.15 [1.09-1.22],6.622712662538378e-07
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,47220,96,1.62 [0.94-2.77],0.0804609278164406
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,47237,113,1.54 [0.93-2.56],0.0949752067650293
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,50910,3849,1.09 [1.00-1.19],0.0571517880532964
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",50913,3845,1.08 [0.99-1.19],0.0753390925092206
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,47226,102,2.14 [1.33-3.44],0.0016404035819029
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,50600,2392,1.09 [0.98-1.23],0.1250677927972874
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",42194,3162,1.71 [1.56-1.88],5.478073980065846e-28
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,51258,457,3.28 [2.76-3.88],1.2584253005370452e-42
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,49371,166,1.45 [0.96-2.21],0.0801273082344965
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,48416,208,1.54 [1.06-2.23],0.0221727721824414
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,48489,281,1.25 [0.90-1.73],0.1881005827605614
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",39366,334,1.78 [1.33-2.38],0.000102607173637
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,46666,307,2.97 [2.42-3.64],1.7885789269855424e-25
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,4212,172,3.74 [2.74-5.11],1.2029375319575596e-16
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,4485,502,2.35 [1.89-2.90],5.615530470783089e-15
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,46483,124,3.14 [2.42-4.07],6.234650481751248e-18
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,4151,114,11.77 [7.65-18.12],4.1367201369868646e-29
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,50008,3649,1.53 [1.40-1.67],7.78408838688018e-22
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,49906,701,1.44 [1.17-1.77],0.0004651147557015
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,46769,724,1.60 [1.31-1.95],3.3227621147875723e-06
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,40558,1526,1.85 [1.62-2.12],8.842142978333212e-19
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",51059,484,1.53 [1.20-1.94],0.0006405833577813
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),49043,330,1.48 [1.10-1.99],0.0101846515370111
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Angina pectoris,46835,2365,1.15 [1.03-1.29],0.0164518776446064
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Aortic aneurysm,49196,483,1.15 [0.89-1.48],0.2927685120590068
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,48831,118,2.55 [1.66-3.90],1.785818148188137e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",49106,393,1.95 [1.51-2.51],3.004439200106507e-07
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,31802,3792,1.32 [1.21-1.45],1.904834245570207e-09
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,AV-block,43209,859,1.46 [1.22-1.75],3.266881813140212e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",51165,846,1.24 [1.03-1.50],0.0239497508638218
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Cardiac arrest,28389,379,2.27 [1.73-2.98],3.648855753336207e-09
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Cardiomyopathy,42685,335,1.65 [1.24-2.21],0.0006534381785219
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",42538,188,1.84 [1.27-2.69],0.0014612847753705
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,51281,100,1.68 [1.00-2.83],0.0521236867678928
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Conduction disorders,44429,2079,1.47 [1.31-1.65],1.2387815958258578e-10
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,48557,4122,1.15 [1.06-1.26],0.0012848035184497
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,44740,15012,1.15 [1.10-1.21],1.111343753939052e-09
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,DVT of lower extremities,48532,523,1.52 [1.20-1.92],0.0004969812537086
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Endocarditis,42494,144,1.34 [0.85-2.11],0.2077707814887489
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,"Heart failure, strict",50873,2174,1.63 [1.46-1.82],7.099107585676261e-18
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Hypertension,46558,12900,1.16 [1.11-1.22],1.4884927837858171e-09
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,"Hypertension, essential",46592,12934,1.17 [1.11-1.23],3.4555953857539513e-10
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,"Hypertension, portal",50938,153,3.57 [2.73-4.67],1.4960330703832366e-20
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",34005,347,2.49 [1.95-3.16],1.1738532188559168e-13
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,33931,273,4.02 [3.34-4.85],1.5460726059409932e-48
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Hypotension,50998,2354,1.58 [1.41-1.77],9.190177893330557e-16
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,49453,216,0.91 [0.62-1.33],0.6118950033313678
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",48899,4429,1.14 [1.05-1.24],0.0023857522962371
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",50538,1113,1.18 [1.00-1.39],0.0476840013570838
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Left bundle-branch block,43062,712,1.49 [1.22-1.82],9.525048593721072e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,50329,1667,1.23 [1.07-1.40],0.002967442859789
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",45876,1406,1.30 [1.12-1.51],0.0004716672963082
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",51099,307,1.09 [0.79-1.49],0.6119664350548957
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",51226,616,1.41 [1.13-1.75],0.00203673948596
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Oesophageal varices,48114,105,2.99 [2.07-4.33],6.4384843779265985e-09
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Other aneurysm,48870,157,1.19 [0.77-1.86],0.4351927554626927
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Other arrhythmias,43189,839,1.63 [1.36-1.95],1.714297904700977e-07
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,48912,199,2.15 [1.51-3.05],2.1455642870299943e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,49192,479,1.94 [1.54-2.46],2.450513254425232e-08
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,42700,350,1.39 [1.03-1.86],0.0289288303089976
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Other disorders of veins,48203,194,1.48 [1.01-2.16],0.0467237868412397
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,48104,95,1.61 [0.93-2.78],0.0902282295682558
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,48437,130,1.10 [0.68-1.79],0.7051564647906343
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,48279,270,1.17 [0.84-1.64],0.3533554454312858
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,44403,2053,1.46 [1.30-1.64],2.462175982393025e-10
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,48752,108,3.48 [2.34-5.19],7.65792383121291e-10
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,49789,1076,2.07 [1.78-2.41],6.45997849113762e-21
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,50063,687,1.89 [1.56-2.28],5.886676408091678e-11
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",49525,1218,1.46 [1.25-1.70],2.069697471241166e-06
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,28679,669,1.53 [1.23-1.89],0.0001020374711945
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Peripheral artery disease,49455,801,2.14 [1.81-2.54],1.848601577710754e-18
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),48691,682,1.38 [1.12-1.70],0.0023292714231064
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Pulmonary embolism,50321,945,0.99 [0.82-1.19],0.9010795225760964
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,51144,1305,1.39 [1.20-1.61],1.5617785638540345e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Right bundle-branch block,43039,689,1.72 [1.42-2.10],5.048445135818429e-08
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Secondary right heart disease,50052,676,1.84 [1.51-2.23],7.556054448124213e-10
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,48692,385,2.03 [1.57-2.61],4.5313230161431983e-08
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",50515,1278,1.14 [0.98-1.33],0.0938634724423874
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",50474,1354,1.19 [1.02-1.38],0.0239904985856863
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,49396,118,1.74 [1.07-2.84],0.0268136683397041
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,48874,162,0.79 [0.51-1.24],0.3100105251232908
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Transient ischemic attack,49895,470,1.13 [0.87-1.46],0.3589812280081016
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,49180,518,1.25 [0.98-1.59],0.0704497861909673
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Varicose veins,48848,839,1.50 [1.25-1.80],1.745021506506379e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,48742,171,1.33 [0.87-2.03],0.1811586359050442
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Venous thromboembolism,50834,1486,1.11 [0.96-1.28],0.1718514969796133
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",51043,717,0.90 [0.73-1.11],0.3107889224146223
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",44877,2826,1.18 [1.06-1.31],0.0024253472787296
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter V Mental and behavioural disorders,Any mental disorder,49986,7935,1.15 [1.08-1.23],7.355076087917011e-06
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",50950,848,0.85 [0.70-1.03],0.0896239464406594
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",45194,3143,1.37 [1.24-1.51],2.682877621420341e-10
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",42231,180,1.47 [0.98-2.20],0.0621813332154765
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter V Mental and behavioural disorders,Smoking dependency,50226,2710,1.09 [0.98-1.22],0.1032582703129877
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",45287,3236,1.03 [0.93-1.14],0.5465811729021947
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter V Mental and behavioural disorders,Vascular dementia,50266,250,1.71 [1.23-2.37],0.0014569579993256
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Alzheimer disease,51282,658,1.30 [1.05-1.61],0.0166094518269572
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,"Alzheimer√ïs disease (Atypical or mixed), excluding more controls",34577,117,1.65 [1.00-2.74],0.0498075965381864
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Bell's palsy,47753,159,1.61 [1.05-2.45],0.0272990541015844
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,48578,984,1.23 [1.03-1.46],0.0224158462077139
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Cerebral cysts,50475,461,1.43 [1.11-1.85],0.00536530502141
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,51124,647,1.49 [1.21-1.84],0.0002153768210169
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,50282,97,1.14 [0.65-2.02],0.6397618607413275
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,51250,122,1.00 [0.61-1.66],0.9858622456716616
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",50163,149,1.01 [0.64-1.61],0.9530950065407268
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Epilepsy,48185,569,1.68 [1.34-2.09],4.594772478831045e-06
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,50332,2716,1.28 [1.15-1.42],4.88518145540551e-06
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,51199,1195,1.20 [1.02-1.41],0.0254077367377169
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Falls/tendency to fall,50097,5139,1.32 [1.22-1.42],2.1940216041001894e-12
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Generalized epilepsy,50524,107,2.76 [1.80-4.24],3.4581703978876133e-06
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Hemiplegia,50981,504,1.68 [1.33-2.12],1.463721663822871e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Hydrocephalus,50136,122,1.45 [0.88-2.38],0.1417083188137288
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,51245,137,1.55 [0.98-2.44],0.0627418393512068
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,47738,144,1.19 [0.75-1.89],0.4584959718097042
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,47751,157,1.60 [1.05-2.46],0.0301411974813298
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Memory loss,49979,216,1.43 [0.98-2.07],0.0604408781031421
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Migraine,48321,705,1.28 [1.04-1.57],0.0214638597735679
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",51147,634,1.25 [1.00-1.55],0.0499227969505635
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Motor neuron disease,34772,274,1.29 [0.92-1.81],0.1417984428747954
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,50950,206,1.09 [0.74-1.60],0.6746977351331152
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",49962,2368,1.27 [1.13-1.42],3.9933991387446005e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Neurological diseases,48349,7482,1.26 [1.18-1.35],1.0573034581167444e-12
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,50587,402,1.62 [1.24-2.11],0.0003796449735914
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",48408,814,1.17 [0.96-1.42],0.1178048612481899
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",51134,587,1.98 [1.62-2.43],4.2612883788937596e-11
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,40796,1288,1.50 [1.28-1.74],2.4097045144688724e-07
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,50159,145,1.30 [0.82-2.06],0.2624943022656876
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Other disorders of nervous system,50287,273,1.56 [1.12-2.16],0.0078615982129123
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,50329,325,1.31 [0.97-1.78],0.0792397720211525
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Other facial nerve disorders,47781,187,1.60 [1.09-2.37],0.017389784738311
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Other headache syndromes,47729,113,1.51 [0.91-2.50],0.1126378618681274
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Other neurological diseases,51041,1027,1.42 [1.20-1.69],5.005964233009105e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Other sleep disorders,48725,1109,1.24 [1.05-1.46],0.0095140328059583
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Parkinson's disease,51237,847,1.17 [0.97-1.41],0.1066707182683555
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,50124,110,1.21 [0.72-2.04],0.4752665790130304
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Restless leg syndrome,51282,155,1.31 [0.84-2.04],0.2265402932306941
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Sleep apnoea,50800,953,1.18 [0.99-1.41],0.0624775701034883
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Small fibre neuropathy,50644,97,2.01 [1.21-3.34],0.0070859825965515
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,51256,329,1.36 [1.00-1.84],0.0472789459730787
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,47695,101,1.36 [0.79-2.35],0.2738215605314763
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,51282,665,1.29 [1.04-1.60],0.0189436167334001
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),50192,243,1.73 [1.24-2.42],0.0011725194418775
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,50143,196,1.02 [0.69-1.53],0.9098490735143152
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,50465,786,0.97 [0.79-1.19],0.7647318152239957
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,50937,463,3.15 [2.66-3.74],2.858576523789731e-40
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,49287,108,0.78 [0.45-1.34],0.3616066273456911
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,49294,115,1.05 [0.62-1.77],0.8507401898725855
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",51068,102,1.95 [1.19-3.21],0.0083130529625499
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,50763,284,0.94 [0.67-1.31],0.7181152539574764
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",4161,121,5.97 [4.47-7.98],1.485540905683574e-33
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,5042,203,3.69 [2.74-4.97],8.773342081578504e-18
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,50135,188,1.28 [0.85-1.90],0.2353313346465311
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,50851,2051,1.31 [1.16-1.48],1.2611355240197938e-05
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",50555,1376,1.03 [0.89-1.20],0.6661869668898978
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,49623,444,1.29 [0.99-1.67],0.0588102345426153
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",51114,1435,1.00 [0.87-1.17],0.9536159936886112
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,51263,132,0.81 [0.49-1.32],0.3878199766270312
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,50965,1286,0.94 [0.81-1.10],0.4679001664739445
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",51196,717,1.06 [0.86-1.30],0.5949242732665978
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,51098,356,1.38 [1.03-1.84],0.0302790896337929
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,49297,118,1.27 [0.77-2.10],0.3510789323210698
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,49308,129,0.76 [0.46-1.25],0.2770189470502684
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,49290,111,1.06 [0.62-1.80],0.8361097132136318
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,51099,1398,1.17 [1.01-1.35],0.0423481334808177
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,50067,366,1.31 [0.99-1.75],0.0608714271438926
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,49775,96,0.76 [0.42-1.35],0.3426342810215649
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,50675,196,1.22 [0.82-1.80],0.3302371224793455
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,51015,536,0.94 [0.74-1.20],0.6226382447228066
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,50063,384,0.81 [0.60-1.08],0.14286086294697
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,50960,218,1.33 [0.92-1.93],0.1281839388925391
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,50628,927,1.17 [0.98-1.40],0.0899318984278336
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,50227,280,1.35 [0.98-1.88],0.0673684571841567
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,48096,4312,1.15 [1.05-1.25],0.0014961524029562
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,50943,464,0.84 [0.65-1.10],0.2015627329480384
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,51244,304,1.43 [1.05-1.95],0.0226377628555563
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,49991,812,0.99 [0.82-1.21],0.9569014752228278
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,50605,126,0.95 [0.58-1.57],0.8473572210049231
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,51239,108,0.78 [0.46-1.35],0.3818623448492126
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,49348,169,1.12 [0.73-1.71],0.6156058212636366
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,49473,294,0.86 [0.62-1.20],0.3759870785321331
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,49036,236,1.36 [0.95-1.94],0.0900226298878433
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,49802,123,1.75 [1.09-2.81],0.0196507181839039
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",48925,125,0.51 [0.31-0.85],0.0104767670882679
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,49873,172,0.95 [0.62-1.46],0.8073793637833405
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",50085,384,1.00 [0.75-1.33],0.9809864635388296
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,49435,256,1.39 [0.99-1.95],0.0564556265140638
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,49023,223,1.06 [0.72-1.54],0.7808760447597142
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,48965,165,1.16 [0.75-1.78],0.5136842499434209
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,47364,3580,1.08 [0.98-1.18],0.1193136835182901
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,49324,145,1.14 [0.72-1.81],0.5678365323023882
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,50766,819,1.20 [0.99-1.45],0.0677348747620403
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,50063,116,0.78 [0.46-1.32],0.3607739439600339
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),50286,339,1.78 [1.34-2.35],6.030154900827679e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,50864,171,1.05 [0.68-1.61],0.8211443026671164
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,51193,238,1.04 [0.72-1.49],0.8406521885140518
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,51018,256,1.48 [1.06-2.08],0.0217039355617056
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,50809,116,2.27 [1.45-3.55],0.0003198327017775
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VIII Diseases of the ear and mastoid process,M¬éni¬ère disease,50815,122,0.98 [0.59-1.62],0.9270002512839812
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,51084,1778,1.17 [1.03-1.34],0.0183978696195511
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,50578,1272,1.22 [1.04-1.42],0.0123370317929879
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,49556,250,1.39 [0.98-1.95],0.061083851895468
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,49477,171,0.93 [0.61-1.44],0.7584234095688
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Acute pharyngitis,50795,151,1.63 [1.06-2.51],0.0262007797096744
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,51071,427,1.77 [1.38-2.28],8.459244479661265e-06
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,50771,127,2.15 [1.40-3.32],0.0005296112611346
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,All influenza,47262,230,2.24 [1.63-3.08],6.75398181374267e-07
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),47257,225,2.17 [1.57-3.01],3.291590270123634e-06
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Allergic asthma (mode),35129,227,0.85 [0.58-1.24],0.3932263329518565
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Allergic rhinitis,51020,552,1.15 [0.91-1.46],0.2510745327059757
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",37869,3494,1.12 [1.02-1.24],0.0172974379329632
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",38344,3442,1.12 [1.02-1.24],0.0178123942448377
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),50470,274,1.99 [1.46-2.70],1.1126630282046498e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",47195,163,2.04 [1.37-3.04],0.0004328888635704
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Bronchiectasis,44470,706,1.54 [1.26-1.89],3.228626781600643e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",43879,115,1.23 [0.73-2.06],0.4363382010942526
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,49274,5510,1.15 [1.07-1.24],0.0001728471591736
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",48562,141,1.42 [0.90-2.24],0.1346146738948243
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Chronic sinusitis,48726,305,1.14 [0.83-1.57],0.406881671576726
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",50893,2357,1.33 [1.19-1.49],9.621613053797789e-07
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Deviated nasal septum,48628,207,0.95 [0.64-1.40],0.7767340004661974
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,47175,10434,1.22 [1.15-1.28],2.913872404433229e-12
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",49133,712,1.16 [0.94-1.43],0.1595488713165877
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Early onset COPD,49159,623,1.25 [1.01-1.56],0.0445733724397756
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Emphysema,44383,619,1.65 [1.33-2.05],6.784386944518544e-06
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,48714,566,1.39 [1.10-1.74],0.0050640678082931
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Influenza and pneumonia,50836,3804,1.56 [1.43-1.71],3.7404746543110025e-24
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Interstitial lung disease,48781,633,1.49 [1.20-1.84],0.0002784056931063
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Later onset COPD,49295,1734,1.35 [1.18-1.54],9.741193626006623e-06
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,51258,658,1.52 [1.23-1.87],8.633675896745291e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Nasal polyp,48635,214,1.69 [1.18-2.43],0.0043568813575882
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,50790,1931,1.42 [1.26-1.61],1.877322618945275e-08
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Other diseases of pleura,50816,3962,1.36 [1.25-1.49],2.0510052251670568e-12
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,50071,1650,1.18 [1.03-1.35],0.0170633969188063
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Other pleural conditions,46952,98,1.05 [0.60-1.86],0.8639860030467201
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,51109,792,1.66 [1.37-2.00],1.213168945724683e-07
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,51074,2583,1.40 [1.26-1.55],7.579358796503905e-10
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Pleural effusion,48835,1981,1.46 [1.30-1.65],7.143311429228098e-10
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Pleural plaque,47160,306,1.20 [0.88-1.65],0.2518898396130892
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",50336,3304,1.61 [1.46-1.76],8.623037282097181e-24
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,51131,531,1.61 [1.28-2.03],4.787962035280282e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Pneumothorax,47081,227,1.01 [0.69-1.47],0.955907376087559
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Pollen allergy,51237,472,1.13 [0.88-1.46],0.3462136405029647
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Pulmonary oedema,50448,131,3.12 [2.23-4.37],3.4309161029556885e-11
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Respiratory insufficiency,35011,109,1.29 [0.75-2.21],0.35142814441539
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,50746,1887,1.45 [1.28-1.64],5.007837038369374e-09
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,48975,554,1.16 [0.92-1.47],0.2144669163594624
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Viral pneumonia,47526,494,1.49 [1.17-1.90],0.0011280942380893
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",50501,411,1.29 [0.99-1.69],0.0588083166139512
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,23653,217,1.38 [0.94-2.01],0.0984111155997708
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,36204,126,1.36 [0.83-2.22],0.228971755614473
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Acute appendicitis,50964,290,0.94 [0.67-1.30],0.6914177710426214
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Acute gastritis,38617,177,1.89 [1.29-2.77],0.0010205531353441
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Acute pancreatitis,47624,361,1.63 [1.23-2.16],0.0005742249433806
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Acute peritonitis,50344,187,2.67 [1.93-3.70],3.408310612016178e-09
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Alcoholic liver disease,49510,148,2.36 [1.58-3.50],2.337687881626233e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Barrett oesophagus,39300,860,1.36 [1.13-1.64],0.0010842666886815
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",47463,200,1.49 [1.02-2.17],0.0375543982777731
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",50440,200,1.45 [1.00-2.12],0.0516562550228819
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Cholecystitis,47664,401,1.13 [0.86-1.50],0.3729270471842014
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Cholelithiasis,49237,1974,1.41 [1.25-1.59],3.7714290248121794e-08
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Chronic gastritis,39044,604,1.39 [1.11-1.73],0.0035558182009191
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Chronic pancreatitis,47361,98,2.16 [1.30-3.58],0.0029433020156354
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",50992,207,3.35 [2.60-4.30],5.064370284009655e-21
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Coeliac disease,48098,246,2.33 [1.73-3.15],3.395007060459401e-08
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Collagenous colitis,47938,160,1.74 [1.15-2.64],0.0092381717933215
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,50978,370,0.96 [0.72-1.29],0.7930916505712129
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Constipation,50766,3318,1.31 [1.19-1.44],2.8251910088197843e-08
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Crohn disease,47962,184,1.96 [1.35-2.85],0.0004049893431155
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",50572,135,2.21 [1.45-3.34],0.0001954766134645
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Crohn's disease NAS,47952,174,2.17 [1.50-3.15],3.979849226401556e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Dental caries,49814,461,1.13 [0.87-1.46],0.3610398210711717
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,46038,4411,1.23 [1.13-1.33],1.416384514273743e-06
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Diseases of appendix,51036,362,0.96 [0.72-1.30],0.8078646496740023
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Diseases of liver,51038,1676,1.55 [1.36-1.77],3.7167304378352645e-11
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",46992,8552,1.18 [1.11-1.25],7.835585363406823e-08
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",50460,1107,1.17 [0.99-1.39],0.0584634151776065
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Diseases of peritoneum,51110,953,1.45 [1.22-1.73],3.334766890220501e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,49581,228,1.16 [0.81-1.68],0.4202954822529723
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Diseases of salivary glands,49287,128,1.67 [1.05-2.66],0.0318755779285193
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Diseases of the digestive system,50664,2812,1.47 [1.33-1.63],9.701899506516029e-14
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Diseases of tongue,49317,219,1.56 [1.08-2.24],0.0170975574811601
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",50041,2778,1.36 [1.23-1.51],4.550595127052904e-09
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,42334,6256,1.10 [1.03-1.18],0.0069185239007225
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Duodenal ulcer,38833,393,1.49 [1.14-1.95],0.0037168446347414
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",51116,316,1.28 [0.94-1.74],0.1175602747558282
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,51110,111,0.69 [0.41-1.19],0.183160958274391
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,49612,250,3.02 [2.35-3.87],3.339242937417136e-18
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,36371,293,0.90 [0.64-1.25],0.5140776476687156
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Functional dyspepsia,39513,1073,0.93 [0.79-1.11],0.4424810295704103
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Gastric ulcer,39155,715,1.33 [1.08-1.63],0.0064566880839707
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,43373,4933,1.12 [1.03-1.21],0.0058644623070205
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,39505,1065,1.42 [1.21-1.68],2.5200923323351925e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,39690,16421,1.16 [1.11-1.21],6.933757355541659e-11
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,GI-bleeding,50159,2307,1.41 [1.26-1.58],2.2840743520460384e-09
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,49461,108,1.28 [0.75-2.17],0.3636014126293851
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,38015,2494,1.11 [0.99-1.24],0.0828449550151536
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",49486,124,2.60 [1.73-3.90],3.683884604741039e-06
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Hernia,48046,6419,1.17 [1.09-1.25],1.13178952111512e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Impacted teeth,51123,103,0.69 [0.39-1.20],0.1882134471412021
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Impaction of intestines,36191,113,2.56 [1.62-4.03],5.02182462260696e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Inguinal hernia,43402,1775,1.07 [0.93-1.22],0.3401124958778606
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",41831,204,0.87 [0.59-1.30],0.4989229646858991
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,36266,188,0.88 [0.58-1.34],0.5624814516494392
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Intestinal malabsorption,48137,285,2.33 [1.76-3.07],3.113958999270952e-09
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,37167,1089,1.36 [1.15-1.60],0.0002939458839554
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,51227,734,1.34 [1.10-1.63],0.0042195487103514
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,49277,1499,1.41 [1.23-1.63],1.3886373477563174e-06
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,49765,1987,1.37 [1.21-1.54],5.826446456196094e-07
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Oesophageal obstruction,38809,369,1.32 [0.99-1.76],0.0556692264219457
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Oesophagitis,39629,1189,1.20 [1.02-1.41],0.0238578695223982
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,51184,270,1.08 [0.77-1.52],0.6541014386720281
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,41761,134,1.38 [0.86-2.21],0.1821341708930509
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,38787,2709,1.22 [1.09-1.35],0.0003627116577846
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,47818,555,1.21 [0.96-1.53],0.1062113432842382
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,47576,313,1.26 [0.92-1.72],0.1468700311197835
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Other diseases of intestine,39546,3468,1.09 [0.99-1.20],0.0682773200850384
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Other diseases of intestines,47277,11199,1.16 [1.10-1.23],1.6563670020885837e-08
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,49271,410,1.25 [0.95-1.64],0.1109756841459168
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Other diseases of liver,50736,1374,1.51 [1.30-1.74],3.102200930861698e-08
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,39746,1306,1.41 [1.21-1.64],7.313761314525362e-06
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Other diseases of pancreas,47567,304,2.32 [1.76-3.05],1.827899883658651e-09
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,50974,817,1.22 [1.00-1.48],0.0462282450134244
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,40326,1886,1.46 [1.29-1.65],3.0907883968434715e-09
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,50188,2336,1.42 [1.27-1.58],1.2673234066990864e-09
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,49728,375,1.20 [0.90-1.59],0.2168385188204177
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,39487,3409,1.35 [1.22-1.48],8.848374186649572e-10
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),42415,3975,1.29 [1.18-1.41],1.1478421834348384e-08
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,49560,198,2.72 [2.01-3.69],1.0335140287429022e-10
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,49525,1747,1.43 [1.25-1.63],7.275291347716204e-08
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",36757,679,1.37 [1.11-1.70],0.0037853033759291
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,51091,129,0.68 [0.41-1.11],0.1247093957633039
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,37046,968,1.32 [1.10-1.57],0.0026686006738258
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",48148,296,1.62 [1.19-2.20],0.0023623957110026
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Recurring oral aphthae,51260,114,1.90 [1.17-3.07],0.0090578260889747
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,49363,234,1.94 [1.39-2.71],9.8690524680847e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Toxic colitis,47888,110,1.57 [0.95-2.61],0.0807259148559977
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,38969,529,1.40 [1.10-1.77],0.0057960256961643
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Ulcerative colitis,48096,318,1.37 [1.01-1.87],0.0422452163970448
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",48041,263,1.34 [0.95-1.87],0.0932670796203155
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Umbilical hernia,42169,542,1.27 [1.00-1.61],0.0454109553748868
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,36423,345,1.55 [1.15-2.08],0.0037189502197555
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Ventral hernia,42138,511,1.47 [1.16-1.87],0.0015966299209118
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Volvulus,36236,158,1.24 [0.79-1.94],0.3477113023203878
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,51118,587,0.95 [0.75-1.20],0.644525682958426
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,50638,144,2.72 [1.91-3.89],3.6884940306578926e-08
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,47222,319,1.41 [1.04-1.92],0.0282409647208204
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,50022,1400,1.65 [1.43-1.90],2.6742061253944145e-12
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",48966,344,1.36 [1.01-1.83],0.0413946923121304
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,47715,812,1.90 [1.59-2.27],1.1594079737347094e-12
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,50675,544,1.24 [0.98-1.57],0.0775263637016702
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,51085,954,1.42 [1.19-1.69],9.97842321130203e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,50226,95,2.51 [1.60-3.96],6.79816402139493e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,48193,6348,1.26 [1.18-1.35],5.72381425521212e-11
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,50385,894,1.03 [0.86-1.25],0.729931730293862
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,50119,628,1.01 [0.81-1.26],0.950760237829184
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,50496,1874,1.54 [1.36-1.74],1.0722337600263493e-11
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",51249,109,1.02 [0.60-1.74],0.9439867935183032
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,47019,116,3.12 [2.16-4.50],1.3272855844014736e-09
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,49595,104,1.47 [0.87-2.46],0.1484988538187673
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,50654,523,1.22 [0.96-1.56],0.1009447184942803
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,47800,897,1.26 [1.04-1.52],0.015374695697756
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,47027,124,0.81 [0.48-1.35],0.4143508064810034
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,51111,165,1.72 [1.15-2.57],0.0086285209975338
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,48985,363,1.65 [1.25-2.17],0.0004367720255122
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,50880,386,1.03 [0.78-1.37],0.8218967560501312
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,50261,130,1.28 [0.80-2.06],0.3043966882547026
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,47036,133,0.74 [0.45-1.21],0.225330356807385
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,50137,3234,1.42 [1.29-1.57],5.039103330128999e-13
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",47876,973,1.34 [1.12-1.60],0.0012256085274709
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,47034,131,0.84 [0.51-1.37],0.4808193755819357
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,51107,613,1.20 [0.96-1.50],0.1074468095449218
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,50270,139,2.31 [1.54-3.46],5.114227751418751e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,50995,501,1.27 [1.00-1.63],0.0523711272713808
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,51175,644,1.01 [0.81-1.26],0.9603076822781018
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,47153,250,1.42 [1.00-2.00],0.0494626995001953
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,47433,530,1.02 [0.80-1.31],0.8669287768221153
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,51153,622,0.98 [0.78-1.23],0.8857908590789307
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",47374,471,2.28 [1.84-2.82],2.902887720872929e-14
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,51220,274,1.43 [1.03-1.98],0.0305216093797368
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,44020,221,1.23 [0.85-1.78],0.2674123564033893
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,46669,11190,1.15 [1.09-1.21],2.525655432880171e-07
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,43854,8375,1.16 [1.10-1.24],1.0563410269842564e-06
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,43949,150,1.31 [0.84-2.06],0.2355872884421672
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,44455,302,1.46 [1.07-1.99],0.0173102937137791
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,44508,355,1.83 [1.39-2.41],1.445985529936493e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,50781,182,1.39 [0.93-2.08],0.103724568317698
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",44348,195,1.84 [1.27-2.68],0.0013080811263055
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,37730,2251,1.07 [0.95-1.21],0.2623330092156337
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",51011,372,1.10 [0.83-1.48],0.4993514003195525
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,45039,886,1.24 [1.03-1.49],0.0232451114629868
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,43354,14401,1.13 [1.08-1.18],4.861965517597993e-07
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,47343,231,1.55 [1.09-2.20],0.0151263900758779
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,44095,296,1.62 [1.19-2.20],0.0023241028727716
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,44928,1129,1.05 [0.89-1.24],0.5845940674704919
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,49440,5287,1.18 [1.09-1.27],2.541101006243569e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,44335,536,1.03 [0.81-1.31],0.8092162424296843
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,44230,431,1.64 [1.27-2.11],0.0001330483066943
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,44065,266,0.94 [0.66-1.33],0.7157414282839603
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,50009,138,0.82 [0.50-1.33],0.418255732439742
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,38829,3350,1.19 [1.08-1.31],0.0004509040016498
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,36677,1198,1.59 [1.36-1.85],4.771230758235224e-09
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",51134,1183,1.49 [1.28-1.73],3.400466767029501e-07
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,35628,149,0.47 [0.29-0.75],0.0015177153411787
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),36135,656,1.47 [1.18-1.81],0.0004265120729815
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,44399,600,0.98 [0.78-1.23],0.8680623774080827
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,36744,1265,1.15 [0.98-1.34],0.0845452470274354
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,44261,108,1.58 [0.95-2.65],0.0802418700016042
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,45400,1247,1.30 [1.11-1.51],0.0010848293998061
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,44757,604,1.18 [0.94-1.48],0.1546783359320369
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,36663,1184,1.13 [0.96-1.32],0.1552504170533275
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,43959,160,1.33 [0.86-2.04],0.1998225346504408
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",43922,123,0.95 [0.57-1.57],0.8398052265119089
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,47254,142,2.56 [1.79-3.66],2.2379558989161893e-07
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,50510,3398,1.36 [1.23-1.49],2.629639925441384e-10
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,49332,2220,1.39 [1.23-1.56],4.1220415825975554e-08
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",50997,895,1.70 [1.43-2.03],2.8992252839998606e-09
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,40416,4937,1.28 [1.18-1.38],1.217145969655741e-09
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,35603,124,0.81 [0.48-1.34],0.4066894358566775
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,43981,182,1.44 [0.97-2.16],0.0739275118731829
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,35577,98,1.67 [0.98-2.85],0.0584089062367802
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),35728,249,1.55 [1.10-2.18],0.0122977483623134
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,47594,482,1.23 [0.96-1.59],0.1015078040161453
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,47868,756,1.27 [1.04-1.55],0.0216371401123664
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,51218,201,1.63 [1.12-2.37],0.0105501517421131
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",47734,3581,1.21 [1.11-1.33],3.96146724261031e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,43997,198,2.00 [1.41-2.86],0.0001242361806136
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),35751,272,1.67 [1.21-2.29],0.0015872193159642
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,45590,1437,1.22 [1.05-1.41],0.0078347751656033
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,39743,4264,1.20 [1.11-1.31],2.0070691321093934e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,50056,185,1.38 [0.92-2.06],0.1222714768314896
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,51245,137,2.91 [2.05-4.13],2.099217795381969e-09
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,43959,160,1.04 [0.67-1.62],0.8618701111581153
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",46270,2471,1.38 [1.24-1.54],7.356612302915767e-09
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,43975,176,1.23 [0.81-1.86],0.3396848438523481
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,38693,3214,1.24 [1.12-1.36],2.232151384960699e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,47335,223,0.89 [0.61-1.30],0.5535350737226163
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,43906,107,1.10 [0.64-1.89],0.7217996553034749
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,44470,317,0.95 [0.69-1.31],0.7611461012305818
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,44894,1095,1.43 [1.21-1.68],1.9732076055320845e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,50570,699,1.59 [1.30-1.95],7.992934331771004e-06
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,45294,1141,1.32 [1.12-1.55],0.0007838263328218
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,51021,870,1.69 [1.42-2.02],6.335353261612985e-09
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,51239,107,1.54 [0.91-2.58],0.1051409094137938
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,44175,376,1.20 [0.90-1.60],0.2136003532076733
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,40596,1500,1.41 [1.23-1.62],1.4552552129145057e-06
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,44956,1157,1.39 [1.18-1.63],5.415940129887754e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],44247,448,0.95 [0.72-1.24],0.6930997378393131
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",35584,105,1.90 [1.17-3.10],0.0098526558173835
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,40404,4925,1.31 [1.22-1.42],7.548071966195734e-12
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,36766,1287,1.56 [1.35-1.81],3.927621192861337e-09
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,50333,462,1.17 [0.90-1.52],0.234485822315055
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",51150,133,2.28 [1.51-3.45],8.771079339744948e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",46986,100,1.66 [0.97-2.83],0.0638669002103982
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,35619,140,2.86 [2.05-3.99],6.67295296765426e-10
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,44357,204,1.03 [0.70-1.53],0.866971980671284
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,36385,906,1.75 [1.47-2.09],2.433717909130044e-10
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,44406,607,1.09 [0.87-1.36],0.4717688078138986
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,44654,501,1.17 [0.91-1.50],0.2124653090559542
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,44528,375,1.46 [1.10-1.93],0.0084305407625817
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,40123,116,1.89 [1.17-3.05],0.0087963851917164
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",51248,116,1.59 [0.97-2.61],0.0662221571816732
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,44968,1169,1.10 [0.93-1.29],0.2603336700376691
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sj¬ögren],50050,179,3.15 [2.36-4.19],3.933110254000881e-15
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,48895,5096,1.23 [1.14-1.33],1.061079392153849e-07
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",44056,257,1.21 [0.86-1.71],0.2778715579639998
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,45228,1075,1.27 [1.07-1.50],0.005199878967211
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,48490,467,0.89 [0.69-1.16],0.3913784714561983
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,44567,414,1.10 [0.83-1.44],0.5029082508992926
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,47235,3082,1.21 [1.10-1.34],0.0001288998772854
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,46179,2026,1.31 [1.16-1.48],1.5503565188305222e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],43904,105,1.26 [0.74-2.16],0.3950915853881438
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,50140,269,2.83 [2.19-3.66],1.6055254013978693e-15
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,44123,324,1.16 [0.85-1.58],0.3557658930241562
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,43947,148,1.38 [0.88-2.17],0.1602245038795861
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),35594,115,1.73 [1.06-2.82],0.0282528158236449
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Acute renal failure,49195,3130,2.22 [2.02-2.43],6.541161229983173e-64
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),20720,103,1.23 [0.72-2.10],0.4431836510405219
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,26955,109,1.01 [0.59-1.72],0.9850099227185948
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,50656,639,1.01 [0.81-1.26],0.924447143500952
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,50182,165,0.71 [0.45-1.10],0.1199528490506194
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,49101,3036,2.85 [2.62-3.09],1.7876081866742548e-136
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,50853,165,4.00 [3.20-5.01],4.263958496839434e-34
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,50796,604,1.22 [0.97-1.52],0.0845099118489302
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Cystitis,45161,464,1.46 [1.14-1.88],0.0031408316750617
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Dialysis,46224,159,6.67 [5.42-8.21],4.763202490094449e-72
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,22345,3304,1.10 [1.00-1.21],0.0560282360888587
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Disorders of breast,27188,342,1.10 [0.81-1.48],0.549789835904658
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Endometriosis,20800,183,1.21 [0.81-1.80],0.3622069224350553
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",21011,394,0.95 [0.72-1.25],0.7066597160598813
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,21631,1014,0.97 [0.82-1.16],0.7639977628058675
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,42801,10663,1.29 [1.22-1.36],1.769474644257425e-20
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,50855,167,4.61 [3.75-5.66],2.9379375361809197e-48
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Hydrocele,19247,206,1.01 [0.68-1.50],0.9508018294256166
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,46049,579,1.39 [1.10-1.76],0.005307162508826
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,21631,2590,1.14 [1.02-1.28],0.0164331764989038
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,27112,400,1.10 [0.83-1.45],0.5062619883935822
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),19273,232,0.90 [0.62-1.30],0.5672302555978631
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Irregular menses,27191,131,0.96 [0.59-1.57],0.8849166653380841
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Menorrhagia,20919,302,0.95 [0.69-1.31],0.7675554280357288
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,44854,157,1.88 [1.25-2.84],0.0025763703410508
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,23093,2476,0.97 [0.87-1.08],0.5815936916865245
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,19150,109,0.81 [0.47-1.40],0.4562148217067377
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,20760,143,1.10 [0.69-1.75],0.6880679917641838
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",51256,128,1.38 [0.86-2.23],0.1865729788939684
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",51266,132,1.77 [1.12-2.78],0.0137155594921288
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,49203,4506,1.36 [1.25-1.47],1.6998470613870065e-13
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,46119,1422,1.20 [1.04-1.39],0.0143245252009312
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,26967,121,1.18 [0.72-1.96],0.5087005462502623
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,51146,954,1.47 [1.24-1.75],1.202549634633156e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,19351,310,1.33 [0.97-1.83],0.0736341986264463
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,19321,280,1.18 [0.85-1.65],0.3297937165956396
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,19271,230,0.86 [0.59-1.25],0.4351520207315704
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,51202,139,1.32 [0.83-2.11],0.2346326472457333
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,48174,3477,1.43 [1.30-1.56],4.373138461632676e-14
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,26920,208,1.26 [0.86-1.85],0.2429882481621628
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,20771,154,0.94 [0.60-1.49],0.8026441824947634
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",20990,373,0.95 [0.71-1.27],0.7266528711626792
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,20728,111,1.04 [0.61-1.77],0.8795253468564441
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,20824,207,0.85 [0.57-1.26],0.4137720355531483
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,46146,676,1.48 [1.20-1.83],0.0003108563879747
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,50505,313,1.52 [1.12-2.06],0.0066144201316054
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,20929,312,1.05 [0.76-1.43],0.7785999378520783
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,20725,108,0.72 [0.42-1.24],0.2360085625991879
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,21269,652,0.85 [0.68-1.06],0.1511665762009043
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,20778,161,0.75 [0.48-1.17],0.2034401252680233
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,21212,595,0.90 [0.71-1.13],0.3480593930871766
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,50784,96,2.21 [1.33-3.66],0.0020881759993879
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",19303,262,1.05 [0.75-1.49],0.7648778203655876
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,50779,5309,2.09 [1.95-2.24],1.3774053982348016e-92
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",45705,235,2.56 [1.88-3.47],1.619334465286235e-09
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,46327,262,3.78 [2.93-4.89],2.268042600776317e-24
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,50124,107,0.97 [0.57-1.67],0.9237086558374166
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Urethral stricture,45142,445,1.32 [1.01-1.71],0.0382757585200897
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Urolithiasis,50804,787,0.97 [0.80-1.19],0.8006061716785601
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Uterine polyps,20756,139,0.60 [0.37-0.97],0.0367278974429265
